Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Cognitive Multidomain Alzheimer's Risk Velocity Study (DC-MARVEL)

NCT04559789 is registered in ClinicalTrials.gov with Neurotrack Technologies, Inc. as lead sponsor.

NCT NCT04559789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04559789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Cognitive Multidomain Alzheimer's Risk Velocity Study (DC-MARVEL)
Lead sponsor
Neurotrack Technologies, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 4, 2021
Completion date
January 30, 2024
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive decline, dementia, mild cognitive impairment